COLL vs T · P/E 17, rev $181.9M vs P/E 7.4, rev $125.65B
Collegium Pharmaceutical Inc (COLL) versus AT&T Inc. (T) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
AT&T Inc. (T) is a telecom services company listed on NYSE. It is led by John Stankey.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported T revenue for 2025-12-31 was $125.65B. Net income was $21.95B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. T currently screens at market cap $155.92B and trailing P/E 7.4.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. T currently screens at market cap $155.92B and trailing P/E 7.4.
Not investment advice. Open the COLL and T stock pages for the full models.
Not investment advice.